Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
5 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Correction: Repotrectinib's Clinical Benefit and Its Brain Penetration in a Patient with Meningeal Carcinomatosis from G2032R-Mutated ROS-1 Positive Non-Small Cell Lung Cancer.
Oncol Ther. 2024 Mar;12(1):173-174. doi: 10.1007/s40487-023-00258-z.
Oncol Ther. 2024.
PMID: 38170387
Free PMC article.
No abstract available.
Repotrectinib's Clinical Benefit and Its Brain Penetration in a Patient with Meningeal Carcinomatosis from G2032R-Mutated ROS-1 Positive Non-Small Cell Lung Cancer.
Metro G, Gariazzo E, Costabile S, Baglivo S, Roila F, Colamartini F, Palumbo B, Chiarini P, Gori S, Conti A, Marcomigni L, Bellezza G, Lunardi G.
Metro G, et al. Among authors: gariazzo e.
Oncol Ther. 2024 Mar;12(1):163-171. doi: 10.1007/s40487-023-00251-6. Epub 2023 Nov 16.
Oncol Ther. 2024.
PMID: 37973688
Free PMC article.
Item in Clipboard
Non-small cell lung cancer: an update on emerging EGFR-targeted therapies.
Favorito V, Ricciotti I, De Giglio A, Fabbri L, Seminerio R, Di Federico A, Gariazzo E, Costabile S, Metro G.
Favorito V, et al. Among authors: gariazzo e.
Expert Opin Emerg Drugs. 2024 Apr 8:1-16. doi: 10.1080/14728214.2024.2331139. Online ahead of print.
Expert Opin Emerg Drugs. 2024.
PMID: 38572595
Review.
Item in Clipboard
A Podcast on Pre- or Perioperative Chemoimmunotherapy for Stage III Non-Small Cell Lung Cancer: Shared Agreement from the Thoracic Surgeon and Oncologist Perspectives.
Bertolaccini L, De Giglio A, Gariazzo E, Metro G.
Bertolaccini L, et al. Among authors: gariazzo e.
Oncol Ther. 2024 Mar 14. doi: 10.1007/s40487-024-00267-6. Online ahead of print.
Oncol Ther. 2024.
PMID: 38483781
Free article.
Item in Clipboard
Navigating challenges in EGFR exon 20 insertions: The PAPILLON trial unravels the promise of amivantamab-chemotherapy.
De Giglio A, Di Federico A, Gariazzo E, Metro G.
De Giglio A, et al. Among authors: gariazzo e.
Med. 2024 Jan 12;5(1):1-3. doi: 10.1016/j.medj.2023.11.006.
Med. 2024.
PMID: 38218173
Item in Clipboard
Cite
Cite